Life Sciences : In The News

Ignite has been rolled into pre-existing plans at Fox Chase to build a center for personalized medicine, says Jeff Boyd, senior vice president of Molecular Medicine. "The Ignite Institute and Fox Chase are working together with Life Technologies to launch what is now the Cancer Genome Institute at Fox Chase," says Boyd. Ignite's founder, Dietrich Stephan, serves as consulting chief scientific officer of the new institute.

If only all the speed and strength of youth could be channeled into power. Turns out, it can. Some colleges and universities have started converting energy from exercise equipment into electricity.

One of those schools is Drexel University in Philadelphia, where student power runs straight into their buildings' power grids. Dan Simmons, director of recreation at Drexel, says a typical 30-minute workout on a treadmill can generate enough energy to hold a light bulb for 2.5 hours.

A haunting new exhibit entitled 'Mummies of the World' is set to open this Saturday. It will be the largest travelling exhibition ever assembled of mummies.

The exhibit will feature 45 mummies of humans and animals, ranging from 250 years old to nearly 6,500 years old.

Temple University physics department chair Rongjia Tao made headlines in 2008 when he developed a simple device that creates an electric field to thin fuel, thereby reducing the size of the droplets injected into the engine and improving fuel efficiency.

Now, Tao and former graduate student Ke Huang are unveiling their latest research that this same principle, when applied to the human body, can help thin blood and reduce one's risk of heart attack--without the side effects of blood thinners such as aspirin.

The Philadelphia company said Thursday earnings in health care, its largest segment, climbed 47 percent, and premiums and fees from its international business rose 32 percent, fueled in part by the purchase of the Belgian company Vanbreda International last year.

In a major breakthrough in the battle against the devastating disease, researchers have pinpointed the chemical 'driving force' behind MS.

Without it, the disease does not develop. And when it is mopped up, symptoms are greatly eased, even in brains already ravaged by the illness.

Johnson & Johnson's plan to buy Synthes for some $20 billion may mean more deals in the sector as rival medical technology firms try to bulk up in tough times, though antitrust issues are a hurdle.

A weak economy and high unemployment have hit sales of medical devices hard, since patients have to take time off and, in the United States, dig deep into their own pockets to help pay for procedures such as knee replacements.

As a result, more and more companies are looking at acquisitions as a way to add new avenues of growth.

Well, writing this week in the journal Nature Genetics, researchers may have found some new clues to the disease. Two big consortia of researchers, one in the U.S., one in Europe, have sifted through the genomes of thousands of Alzheimer's patients and have come up with a handful of genes that seem to be linked to the condition. 

Source: NPR
Read the full story here.